Seeking Alpha

MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • STAAR Surgical Co. (STAA) Updates on Product Launch, Participation in 2011 Congress of European Society of Cataract and Refractive Surgeons 0 comments
    Sep 15, 2011 2:37 PM | about stocks: STAA
    STAAR Surgical Company, a leading developer of minimally invasive ophthalmic products, today detailed is activities scheduled before and during the 2011 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) this weekend, during which the company will officially launch two key products in Europe and other countries that accept CE Mark approvals.
    The Congress will be held in Vienna, Austria, September 17 through 21, 2011. STAAR will launch its Visian Implantable Collamer® Lens (NYSE:ICL) with CentraFLOW™ technology, which utilizes the KS-AquaPORT™, and the nanoFLEX™ IOL, both of which the company received CE Mark approval for in April 2011.
    Beginning tomorrow, STAAR will hold its 8th Annual Visian ICL Experts Symposium. The company said it anticipates more than 100 surgeons from 34 countries to attend the “by invitation only” roundtable discussion sessions on the Visian ICL technology.
    Hans Blickensdoerfer, president of Europe and Latin America for STAAR, said the meeting not only represents the official unveiling of its key products, but is also a celebration of a recent significant achievement.
    “We anticipate this will be the most exciting and productive ESCRS meeting in our history,” Blickensdoerfer stated in the press release. “We will be celebrating the key milestone of over a quarter of a million successful Visian ICL implants at the same time we are introducing the new Visian ICL with CentraFLOW technology.”
    Blickensdoerfer said that over its 15-year history with Visian ICL, it has become the fastest growing refractive technology in the world.
    “Now, for the first time in our history, the Visian ICL can treat all LASIK eligible patients and more, while the procedure is as convenient for both the patient and surgeon, if not more so, than LASIK. In other words, we are now on at least an equal playing level with LASIK and we believe with even better visual results for the patient,” he stated.
    The ESCRS Congress official program begins Saturday and will include more than 50 presentations in which the Visian ICL technology will be presented.
    On Monday, STAAR will host the ESCRS Lunch Symposium entitled, “Revolutions in Refractive Surgery,” which is expected to draw up to 400 surgeons. The luncheon will include six presentations by surgeons from six different countries detailing their experience with the Visian ICL technology, including the new Visian ICL with CentraFLOW technology.
    For more information visit
    Please see disclaimer on the MissionIR website ;
    Stocks: STAA
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.